RxDoctor Payments Data

Jared Beller, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Charlottesville, VANPI 1225423510

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,111 of the $4,750 with a category attached, or 65.5%. Atricure, Inc. accounts for 63.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $2,804 and has fallen 73.3% since, to $749 in 2025.

$4,750in general payments, 2019–2025

Across 43 payments — averaging $110.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$3K
  • Medtronic$599
  • Johnson & Johnson$470
  • Hemosonics LLC$217
  • Abbott$166
  • Abiomed$130
  • plus $174 from 2 others
$39,780in research payments, 2019–2025

Across 3 payments — averaging $13,260 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$40K

What the payments were for

  • Travel & lodging$1,63935%
  • Food & beverage$3,11165%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,750 in reported general payments places this provider in the 55th percentile of 109 thoracic surgery (cardiothoracic vascular surgery) providers in Virginia.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Virginia

Medicare billing

Part B allowed, 2024
$112,337
Medicare patients
131
Services billed
241

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Charlottesville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →